Clinical Trials Browser

Phase 3 × OTHER × Prostate Cancer Metastatic × Clear all

NCT06320067 2025-09-26

STAMPEDE2

Phase 3 Recruiting

Prostate Cancer Metastatic

NCT04916613 2024-09-26

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Phase 3 Recruiting

Prostate Cancer Metastatic

NCT02961257 2022-05-12

CABASTY

Phase 3 Completed

Prostate Cancer Metastatic